Soft Tissue Repair Global Market – Forecast To 2023

Publishing Date : April, 2017
Report Code : HCMD0145
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Muscles, ligaments, tendons, fat and connective tissue constitutes soft tissue, where as Bones, cartilage and dental enamel is considered to be hard tissues. Damage to these Soft tissues are repaired by procedures that include hernia repair, cardiac repair, breast reconstruction, dental reconstruction, skin repair, etc. It does not include procedures that involve whole organ transplant and tissue regeneration and consist of products that are essential for patients suffering with soft tissue injuries and damage. With the projected rise in aged population, sports injuries and increased number of medical procedures such as hernia repair, cardiac repair, vaginal sling procedures, dental reconstruction, skin repair, etc. The market is focused on growing with newer technology and improved products. According to IQ4I analysis, the soft tissue repair global market is expected to grow at high single digit CAGR to reach $21,319.7 million by 2023. Factors driving the soft tissue repair market include, increase in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are  contributing to the growth of soft tissue repair global market. Lack of awareness, limited reimbursements and high cost of procedures are hampering the market growth. Advancement of technology with its wide application areas shows that soft tissue repair market has vast opportunities in the coming years.

Soft tissue repair global market is classified based on products, surgeries, applications, and geography. The products segment is divided into four segments i.e., meshes/tissue patches, fixation devices, cardiac repair devices and others. Where, the meshes/tissue patches are further classified into synthetic meshes (absorbable meshes and non-absorbable meshes) and biological meshes (allografts tissue patches and Xenograft). The fixation devices market included products such as suture anchors, interference screws and others. The cardiac repair devices market included products such as heart valves (mechanical heart valve, biologic heart valve) and others. While, the others market includes products such as cornea, otologic grafts, cardiac grafts and tendons and ligament grafts. Soft tissue repair market based on surgery is classified into open surgery and minimally invasive surgery (laparoscopy, arthroscopy, catheter based surgery and robotic surgery).

Based on application, the soft tissue repair products are segmented into hernia repair, dental reconstruction, vaginal sling procedure, skin repair, breast reconstruction, orthopedic (dural repair and sports medicine), cardiac repair (transcatheter aortic valve replacement, mechanical heart valve replacement, biological heart valve replacement, annuloplasty ring, MitraClip, occluders, stent grafts and cardiac tissue patches).

Based on geography soft tissue repair global market is classified as North America, Europe, Asia Pacific and Rest of the world. North America accounts for the highest market share followed by Europe. The steep rise in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are driving factors of soft tissue repair products market. However, Asian countries especially China and India are the fastest growing regions with its growing demand for soft tissue repair products.

Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc.

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASED INCIDENTS OF SOFT TISSUE INJURIES
        • 3.3.1.2     RISE IN AGEING POPULATION
        • 3.3.1.3     TECHNOLOGICAL ADVANCEMENTS
        • 3.3.1.4     INCREASE IN INVESTMENTS AND GROWTH IN EMERGING MARKETS.
      • 3.3.2     RESTRAINS AND THREATS
        • 3.3.2.1     LACK OF AWARENESS
        • 3.3.2.2     LIMITED REIMBURSEMENT
        • 3.3.2.3     HIGH COST OF PRODUCTS
        • 3.3.2.4     STRICT REGULATIONS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     CHINA
      • 3.4.4     INDIA
      • 3.4.5     JAPAN
      • 3.4.6     AUSTRALIA
    • 3.5     REIMBURSEMENT SCENARIO
    • 3.6     PATENT ANALYSIS
    • 3.7     TECHNOLOGY ADVANCEMENTS
      • 3.7.1     IMPLANT DESIGN
      • 3.7.2     BIOMATERIAL ADVANCEMENTS
    • 3.8     FUNDING SCENARIO
    • 3.9     SOFT TISSUE REPAIR PRODUCTS - DEALS
    • 3.10     UPCOMING TECHNOLOGY AND PRODUCT LAUNCH
    • 3.11     CLINICAL TRIALS
    • 3.12     PORTER’S FIVE FORCE ANALYSIS
      • 3.12.1     THREAT OF NEW ENTRANTS
      • 3.12.2      THREAT OF SUBSTITUTES
      • 3.12.3     BARGAINING POWER OF SUPPLIERS
      • 3.12.4     BARGAINING POWER OF BUYERS
      • 3.12.5     COMPETITIVE RIVALRY
    • 3.13     SUPPLY CHAIN ANALYSIS
      • 3.13.1     RAW MATERIAL SUPPLIER:
      • 3.13.2     ORIGINAL EQUIPMENT MANUFACTURERS (OEM):-
      • 3.13.3     PRODUCT MANUFACTURERS:-
      • 3.13.4     SOFT TISSUE REPAIR PRODUCTS DISTRIBUTORS:
      • 3.13.5     END-USERS
    • 3.14     MARKET SHARE ANALYSIS
  • 4     SOFT TISSUE REPAIR GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     MESH/TISSUE PATCHES
      • 4.2.1     SYNTHETIC MESHES
        • 4.2.1.1      ABSORBABLE MESHES
        • 4.2.1.2     NON-ABSORBABLE MESHES
      • 4.2.2     BIOLOGICAL MESHES
        • 4.2.2.1      ALLOGRAFT
        • 4.2.2.2     XENOGRAFT
    • 4.3     FIXATION DEVICES
      • 4.3.1     SUTURE ANCHORS
      • 4.3.2     INTERFERENCE SCREWS
      • 4.3.3     OTHER FIXATION DEVICES
    • 4.4     CARDIAC REPAIR DEVICES
      • 4.4.1     HEART VALVES
        • 4.4.1.1      MECHANICAL HEART VALVES
        • 4.4.1.2     BIOLOGICAL HEART VALVES (TISSUE VALVES)
      • 4.4.2     OTHER CARDIAC REPAIR DEVICES
    • 4.5     OTHERS
      • 4.5.1     CORNEAL TRANSPLANTATION
      • 4.5.2     OTOLOGIC GRAFT
      • 4.5.3     CARDIAC GRAFTS
      • 4.5.4     TENDONS AND LIGAMENT GRAFTS
  • 5     SOFT TISSUE REPAIR GLOBAL MARKET, BY SURGERY
    • 5.1     INTRODUCTION
    • 5.2     OPEN SURGERY
    • 5.3     MINIMALLY INVASIVE SURGERY
      • 5.3.1     LAPAROSCOPIC SURGERY
      • 5.3.2     ARTHROSCOPIC SURGERY
      • 5.3.3     CATHETER-BASED SURGERY
      • 5.3.4     ROBOTIC SURGERY
  • 6     SOFT TISSUE REPAIR GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     HERNIA REPAIR
      • 6.2.1     INGUINAL HERNIA REPAIR
      • 6.2.2     INCISIONAL HERNIA REPAIR
      • 6.2.3     UMBILICAL HERNIA REPAIR
      • 6.2.4     OTHER HERNIA REPAIRS
    • 6.3     DENTAL RECONSTRUCTION
    • 6.4     VAGINAL SLINGS
    • 6.5     SKIN REPAIR
    • 6.6     BREAST RECONSTRUCTION
    • 6.7     ORTHOPEDIC
      • 6.7.1     DURAL REPAIR
      • 6.7.2     SPORTS MEDICINE
        • 6.7.2.1     ANTERIOR CRUCIATE LIGAMENT (ACL) REPAIR
        • 6.7.2.2     ROTATOR CUFF REPAIR
        • 6.7.2.3     ACHILLES TENDON REPAIR
        • 6.7.2.4     OTHER REPAIRS
    • 6.8     CARDIAC REPAIR
      • 6.8.1     TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
      • 6.8.2     MECHANICAL HEART VALVES REPLACEMENT
      • 6.8.3     BIOLOGICAL HEART VALVE REPLACEMENT
      • 6.8.4     ANNULOPLASTY RING
      • 6.8.5     MITRACLIP
      • 6.8.6     OCCLUDERS
      • 6.8.7     STENT GRAFTS AND CARDIAC TISSUE PATCHES
    • 6.9     OTHER SOFT TISSUE REPAIRS
  • 7     SOFT TISSUE REPAIR MARKET, BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     U.K.
      • 7.3.4     OTHERS
    • 7.4     ASIA-PACIFIC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     OTHERS
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST & OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     APPROVALS
    • 8.3     ACQUISITIONS & MERGERS
    • 8.4     NEW PRODUCT LAUNCHES
    • 8.5     AGREEMENTS
    • 8.6     OTHER STRATEGIES
  • 9     MAJOR COMPANIES
    • 9.1     ABBOTT LABORATORIES
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ACELITY L.P. INC (ALLERGAN)
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     ARTHREX INC.
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     C.R.BARD INC.
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     EDWARDS LIFESCIENCES CORP.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     INTEGRA LIFESCIENCES CORPORATION
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     JOHNSON & JOHNSON
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     LIVANOVA, PLC
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     MEDTRONIC, PLC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     ORGANOGENESIS, INC.
      • 9.10.1      OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     SMITH & NEPHEW, PLC
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS
    • 9.12     ZIMMER BIOMET HOLDINGS, INC
      • 9.12.1     OVERVIEW
      • 9.12.2     FINANCIALS
      • 9.12.3     PRODUCT PORTFOLIO
      • 9.12.4     KEY DEVELOPMENTS
      • 9.12.5     BUSINESS STRATEGY
      • 9.12.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 2     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 3     MESHES/TISSUE PATCHES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 4     MESHES/TISSUE PATCHES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 5     SYNTHETIC MESHES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 6     BIOLOGICAL MESHES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 7     ALLOGRAFT GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 8     XENOGRAFT GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 9     FIXATION DEVICES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 10     FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 11     SUTURE ANCHORS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 12     INTERFERENCE SCREWS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 13     OTHER FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 14     CARDIAC REPAIR DEVICES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 15     CARDIAC REPAIR DEVICES GLOBAL MARKET REVENUE,BY REGION (2015-2023) ($MN)
      • TABLE 16     HEART VALVES GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 17     MECHANICAL HEART VALVE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 18     BIOLOGICAL HEART VALVE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 19     OTHER CARDIAC REPAIR DEVICES GLOBAL MARKET REVENUE,BY REGION (2015-2023) ($MN)
      • TABLE 20     OTHER SOFT TISSUE REPAIR DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 21     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • TABLE 22     OPEN SURGERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     MINIMALLY INVASIVE SURGERY GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 24     MINIMALLY INVASIVE SURGERY GLOBAL MARKET REVENUE,BY REGION (2015-2023) ($MN)
      • TABLE 25     LAPAROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 26     ARTHROSCOPIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 27     CATHETER-BASED SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 28     ROBOTIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 29     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY APPLICATION (2015-2023) ($MN)
      • TABLE 30     HERNIA REPAIR GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 31     HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 32     INGUINAL HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 33     INCISIONAL HERNIA REPAIR GLOBAL MARKET REVENUE,BY REGION (2015-2023) ($MN)
      • TABLE 34     UMBILICAL HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 35     OTHER HERNIA REPAIRS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 36     HERNIA MESH NUMBER OF UNITS SOLD, BY REGION, (2016-2023) (NO’S)
      • TABLE 37     DENTAL RECONSTRUCTION GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 38     VAGINAL SLINGS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 39     SKIN REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 40     BREAST RECONSTRUCTION GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 41     BREAST RECONSTRUCTION PATCH NUMBER OF UNITS SOLD,BY REGION, (2016-2023) (NO’S)
      • TABLE 42     ORTHOPEDIC GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 43     DURAL REPAIR PATCH GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 44     DURAL REPAIR PATCHES NUMBER OF UNITS SOLD, BY REGION, (2016-2023) (NO’S)
      • TABLE 45     SPORTS MEDICINE GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 46     SPORTS MEDICINE GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 47     ACL REPAIR GLOBAL MARKET REVENUE, BY REGION (2016-2023) ($MN)
      • TABLE 48     ACL REPAIR DEVICES NUMBER OF UNITS SOLD,BY REGION, (2015-2023) (NO’S)
      • TABLE 49     ROTATOR CUFF REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 50     ROTATOR CUFF REPAIR DEVICES NUMBER OF UNITS SOLD, BY REGION, (2015-2023) (NO’S)
      • TABLE 51     ACHILLES TENDON REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 52     ACHILLES TENDON REPAIR DEVICES NUMBER OF UNITS SOLD, BY REGION, (2015-2023) (NO’S)
      • TABLE 53     OTHER REPAIRS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 54     CARDIAC REPAIR GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 55     CARDIAC REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 56     TAVR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 57     MECHANICAL HEART VALVE REPALCEMENT GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 58     BIOLOGICAL HEART VALVE REPALCEMENT GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 59     ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 60     MITRACLIP GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 61     OCCLUDERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 62     STENT GRAFTS & CARDIAC PATCHES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 63     OTHER SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 64     OTHER SOFT TISSUE REPAIRS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 65     CORNEAL IMPLANTS NUMBER OF UNITS SOLD, BY REGION, (2015-2023) (NO’S)
      • TABLE 66     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 67     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 68     NORTH AMERICA MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 69     NORTH AMERICA SYNTHETIC MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 70     NORTH AMERICA BIOLOGICAL MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 71     NORTH AMERICA FIXATION DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 72     NORTH AMERICA CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 73     NORTH AMERICA HEART VALVE DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 74     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • TABLE 75     NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 76     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2015-2023) ($MN)
      • TABLE 77     NORTH AMERICA HERNIA REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 78     NORTH AMERICA ORTHOPEDIC MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 79     NORTH AMERICA SPORTS MEDICINE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 80     NORTH AMERICA CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 81     NORTH AMERICA OTHER APPLICATIONS MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 82     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 83     NORTH AMERICA MESHES/TISSUE PATCHES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 84     NORTH AMERICA FIXATION DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 85     NORTH AMERICA CARDIAC REPAIR DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 86     NORTH AMERICA OTHER PRODUCTS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 87     NORTH AMERICA OPEN SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 88     NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 89     NORTH AMERICA HERNIA REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 90     NORTH AMERICA DENTAL RECONSTRUCTION MARKET REVENUE,BY COUNTRY (2015-2023) ($MN)
      • TABLE 91     NORTH AMERICA VAGINAL SLING PROCEDURES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 92     NORTH AMERICA SKIN REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 93     NORTH AMERICA BREAST RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 94     NORTH AMERICA ORTHOPEDIC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 95     NORTH AMERICA CARDIAC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 96     NORTH AMERICA OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 97     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 98     EUROPE MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 99     EUROPE SYNTHETIC MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 100     EUROPE BIOLOGICAL MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 101     EUROPE FIXATION DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 102     EUROPE CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 103     EUROPE HEART VALVE DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 104     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • TABLE 105     EUROPE MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 106     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2015-2023) ($MN)
      • TABLE 107     EUROPE HERNIA REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 108     EUROPE ORTHOPEDIC MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 109     EUROPE SPORTS MEDICINE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 110     EUROPE CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 111     EUROPE OTHER APPLICATIONS MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 112     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 113     EUROPE MESHES/TISSUE PATCHES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 114     EUROPE FIXATION DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 115     EUROPE CARDIAC REPAIR DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 116     EUROPE OTHER PRODUCTS MARKET REVENUE,BY COUNTRY (2015-2023) ($MN)
      • TABLE 117     EUROPE OPEN SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 118     EUROPE MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 119     EUROPE HERNIA REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 120     EUROPE DENTAL RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 121     EUROPE VAGINAL SLING PROCEDURES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 122     EUROPE SKIN REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 123     EUROPE BREAST RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 124     EUROPE ORTHOPEDIC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 125     EUROPE CARDIAC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 126     EUROPE OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 127     APAC SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 128     ASIA-PACIFIC MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 129     ASIA-PACIFIC SYNTHETIC MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 130     ASIA-PACIFIC BIOLOGICAL MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 131     ASIA-PACIFIC FIXATION DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 132     ASIA-PACIFIC CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 133     ASIA-PACIFIC HEART VALVE DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 134     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • TABLE 135     ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 136     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2015-2023) ($MN)
      • TABLE 137     ASIA-PACIFIC HERNIA REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 138     ASIA-PACIFIC ORTHOPEDIC MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 139     ASIA-PACIFIC SPORTS MEDICINE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 140     ASIA-PACIFIC CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 141     ASIA-PACIFIC OTHER APPLICATIONS MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 142     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 143     ASIA-PACIFIC MESHES/TISSUE PATCHES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 144     ASIA-PACIFIC FIXATION DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 145     ASIA-PACIFIC CARDIAC REPAIR DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 146     ASIA-PACIFIC OTHER PRODUCTS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 147     ASIA-PACIFIC OPEN SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 148     ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 149     ASIA-PACIFIC HERNIA REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 150     ASIA-PACIFIC DENTAL RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 151     ASIA-PACIFIC VAGINAL SLING PROCEDURES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 152     ASIA-PACIFIC SKIN REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 153     ASIA-PACIFIC BREAST RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 154     ASIA-PACIFIC ORTHOPEDIC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 155     ASIA-PACIFIC CARDIAC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 156     ASIA-PACIFIC OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 157     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • TABLE 158     ROW MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 159     ROW SYNTHETIC MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 160     ROW BIOLOGICAL MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 161     ROW FIXATION DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 162     ROW CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 163     ROW HEART VALVE DEVICES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 164     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • TABLE 165     ROW MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 166     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2015-2023) ($MN)
      • TABLE 167     ROW HERNIA REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 168     ROW ORTHOPEDIC MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 169     ROW SPORTS MEDICINE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 170     ROW CARDIAC REPAIR MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 171     ROW OTHER APPLICATIONS MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 172     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 173     ROW MESHES/TISSUE PATCHES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 174     ROW FIXATION DEVICES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 175     ROW CARDIAC REPAIR DEVICES MARKET REVENUE,
      • TABLE 176     ROW OTHER PRODUCTS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 177     ROW OPEN SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 178     ROW MINIMALLY INVASIVE SURGERY MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 179     ROW HERNIA REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 180     ROW DENTAL RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 181     ROW VAGINAL SLING PROCEDURES MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 182     ROW SKIN REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 183     ROW BREAST RECONSTRUCTION MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 184     ROW ORTHOPEDIC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 185     ROW CARDIAC REPAIR MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 186     ROW OTHER APPLICATIONS MARKET REVENUE, BY COUNTRY (2015-2023) ($MN)
      • TABLE 187     APPROVALS (2015-2017)
      • TABLE 188     ACQUISITIONS & MERGERS (2015-2017)
      • TABLE 189     NEW PRODUCT LAUNCHES (2015-2016)
      • TABLE 190     AGREEMENTS (2015-2017)
      • TABLE 191     OTHERS (2015-2017)
      • TABLE 192     ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 193     ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 194     ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 195     ACELITY L.P. INC. : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 196     ACELITY L.P. INC. : TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 197     ACELITY L.P. INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 198     C.R.BARD, INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 199     C.R.BARD, INC: TOTAL REVENUE BY SEGMENTS (2014-16) ($MN)
      • TABLE 200     C.R. BARD, INC: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 201     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 202     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 203     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 204     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 205     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 206     INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 207     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 208     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 209     JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS (2014-2016) ($MN)
      • TABLE 210     JOHNSON & JOHNSON: TOTAL REVENUE, BY SURGERY SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 211     JOHNSON & JOHNSON: TOTAL REVENUE, BY ORTHOPAEDICS SUB-SEGMENTS (2014-2016) ($MN)
      • TABLE 212     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 213     LIVANOVA, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 214     LIVANOVA, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 215     LIVANOVA, PLC: TOTAL REVENUE BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 216     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 217     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 218     MEDTRONIC, PLC: MINIMALLY INVASIVE THERAPIES REVENUE, BY SUB-SEGMENTS (2014-2016) ($MN)
      • TABLE 219     MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 220     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 221     SMITH & NEPHEW, PLC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 222     SMITH &NEPHEW, PLC : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 223     SMITH &NEPHEW, PLC : TOTAL REVENUE, BY SUB-SEGMENTS (2014-2016) ($MN)
      • TABLE 224     SMITH & NEPHEW, PLC : TOTAL REVENUE, BY GEOGRAPHY (2014 -2016) ($MN)
      • TABLE 225     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 226     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 227     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: SOFT TISSUE REPAIR GLOBAL MARKET
      • FIGURE 3     SOFT TISSUE REPAIR GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     SOFT TISSUE REPAIR GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     SOFT TISSUE REPAIR : MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     SOFT TISSUE REPAIR GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     SOFT TISSUE REPAIR GLOBAL MARKET:PATENT FILING BY MAJOR PLAYERS (2012-2016)
      • FIGURE 9     SOFT TISSUE REPAIR GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     SOFT TISSUE REPAIR GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     SOFT TISSUE REPAIR GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 12     HERNIA MESH GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 13     CARDIAC REPAIR DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 14     BREAST RECONSTRUCTION PATCH GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 15     SPORTS MEDICINE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 16     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)
      • FIGURE 17     MESHES/TISSUE PATCHES GLOBAL MARKET SHARE, BY REGION (2016) (%) & CAGR (%)
      • FIGURE 18     MESHES/TISSUE PATCHES GLOBAL MARKET SHARE, BY TYPE (2015-2023) ($MN)
      • FIGURE 19     SYNTHETIC MESHES GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 20     BIOLOGICAL MESHES GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 21     FIXATION DEVICES GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 22     FIXATION DEVICES GLOBAL MARKET SHARE, BY REGION (2016) (%) & CAGR (%)
      • FIGURE 23     CARDIAC REPAIR DEVICES GLOBAL MARKET REVENUE, BY TYPE (2015 - 2023) ($MN)
      • FIGURE 24     CARDIAC REPAIR DEVICES GLOBAL MARKET SHARE, BY REGION (2016) (%) & CAGR (%)
      • FIGURE 25     HEART VALVES GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 26     OTHER SOFT TISSUE REPAIR DEVICES GLOBAL MARKET SHARE, BY REGION (2016) (%) & CAGR (%)
      • FIGURE 27     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY SURGERY (2015-2023) ($MN)
      • FIGURE 28     OPEN SURGERY GLOBAL MARKET REVENUE,BY REGION (2016 VS 2023) ($MN)
      • FIGURE 29     MINIMALLY INVASIVE SURGERY GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 30     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 31     HERNIA REPAIR GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 32     HERNIA REPAIR GLOBAL MARKET SHARE, BY REGION (2016 VS 2023) (%)
      • FIGURE 33     SKIN REPAIR GLOBAL MARKET SHARE, BY REGION (2016 VS 2023) (%)
      • FIGURE 34     BREAST RECONSTRUCTION GLOBAL MARKET REVENUE, BY REGION (2016 VS 2023) ($MN)
      • FIGURE 35     ORTHOPEDIC GLOBAL MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • FIGURE 36     DURAL REPAIR PATCH GLOBAL MARKET REVENUE, BY REGION (2016 VS 2023) ($MN)
      • FIGURE 37     SPORTS MEDICINE GLOBAL MARKET SHARE, BY TYPE (2016) (%)
      • FIGURE 38     SPORTS MEDICINE GLOBAL MARKET SHARE, BY REGION (2016) (%)
      • FIGURE 39     CARDIAC REPAIR GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 40     CARDIAC REPAIR GLOBAL MARKET REVENUE, BY REGION (2016 VS 2023) ($MN)
      • FIGURE 41     OTHER SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 42     SOFT TISSUE REPAIR GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 43     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN)
      • FIGURE 44     NORTH AMERICA MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • FIGURE 45     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY(2015-2023), BY MINIMALLY INVASIVE SURGERY (2016 VS 2023) ($MN)
      • FIGURE 46     NORTH AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 47     NORTH AMERICA SPORTS MEDICINE MARKET SHARE, BY TYPE (%) (2016)
      • FIGURE 48     NORTH AMERICA CARDIAC REPAIR MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 49     U.S. SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 50     U.S. SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 51     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 52     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION, (2016 VS 2023) ($MN)
      • FIGURE 53     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN)
      • FIGURE 54     EUROPE MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • FIGURE 55     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023), BY MINIMALLY INVASIVE SURGERY (2016 VS 2023) ($MN)
      • FIGURE 56     EUROPE SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION, (2016 VS 2023) ($MN)
      • FIGURE 57     EUROPE SPORTS MEDICINE MARKET SHARE, BY TYPE (%) (2016)
      • FIGURE 58     EUROPE CARDIAC REPAIR MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 59     GERMANY SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 60     GERMANY SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION, (2016 VS 2023) ($MN)
      • FIGURE 61     FRANCE SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 62     FRANCE SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 63     U.K. SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 64     U.K. SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 65     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 66     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 67     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN)
      • FIGURE 68     ASIA-PACIFIC MESHES/TISSUE PATCHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • FIGURE 69     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023), BY MINIMALLY INVASIVE SURGERY (2016 VS 2023) ($MN)
      • FIGURE 70     ASIA-PACIFIC SOFT TISSUE REPAIR MARKET REVENUE,BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 71     ASIA-PACIFIC SPORTS MEDICINE MARKET SHARE, BY TYPE (%) (2016)
      • FIGURE 72     ASIA-PACIFIC CARDIAC REPAIR MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 73     JAPAN SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 74     JAPAN SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 75     CHINA SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 76     CHINA SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 77     INDIA SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 78     INDIA SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 79     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 80     OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 81     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016-2023) ($MN)
      • FIGURE 82     ROW SYNTHETIC MESHES MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • FIGURE 83     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY SURGERY (2015-2023), BY MINIMALLY INVASIVE SURGERY (2016 VS 2023) ($MN)
      • FIGURE 84     ROW SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 85     ROW SPORTS MEDICINE MARKET SHARE, BY TYPE (%) (2016)
      • FIGURE 86     ROW CARDIAC REPAIR MARKET REVENUE, BY TYPE (2016 VS 2023) ($MN)
      • FIGURE 87     BRAZIL SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 88     BRAZIL SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 89     REST OF LATIN AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 90     REST OF LATIN AMERICA SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 91     MIDDLE EAST & OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY PRODUCT, (2016 VS 2023) ($MN), BY SURGERY (2015-2023) ($MN)
      • FIGURE 92     MIDDLE EAST & OTHERS SOFT TISSUE REPAIR MARKET REVENUE, BY APPLICATION (2016 VS 2023) ($MN)
      • FIGURE 93     KEY GROWTH STRATEGIES, (2015 – 2017)
      • FIGURE 94     OVERVIEW: ABBOTT LABORATORIES
      • FIGURE 95     SWOT: ABBOTT LABORATORIES
      • FIGURE 96     OVERVIEW: ACELITY L.P. INC.
      • FIGURE 97     SWOT: ACELITY L.P. INC.
      • FIGURE 98     SWOT: ARTHREX, INC.
      • FIGURE 99     OVERVIEW: C.R.BARD
      • FIGURE 100     SWOT: C.R.BARD, INC.
      • FIGURE 101     OVERVIEW: EDWARDS LIFESCIENCES
      • FIGURE 102     SWOT: EDWARDS LIFESCIENCES
      • FIGURE 103     OVERVIEW: INTEGRA LIFESCIENCES CORPORATION
      • FIGURE 104     SWOT: INTEGRA LIFESCIENCES CORPORATION
      • FIGURE 105     OVERVIEW: JOHNSON & JOHNSON
      • FIGURE 106     SWOT: JOHNSON & JOHNSON
      • FIGURE 107     OVERVIEW: LIVANOVA PLC
      • FIGURE 108     SWOT: LIVANOVA, PLC
      • FIGURE 109     OVERVIEW: MEDTRONIC, PLC
      • FIGURE 110     SWOT: MEDTRONIC, PLC
      • FIGURE 111     SWOT: ORGANOGENESIS, INC.
      • FIGURE 112     OVERVIEW: SMITH AND NEPHEW, PLC
      • FIGURE 113     SWOT: SMITH & NEPHEW, PLC
      • FIGURE 114     OVERVIEW: ZIMMER BIOMET HOLDINGS, INC
      • FIGURE 115     SWOT: ZIMMER BIOMET HOLDINGS, INC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     A.M.I. GMBH
      • 2     ABBOTT LABORATORIES
      • 3     ABISS
      • 4     ADMEDUS
      • 5     ADVANCED MEDICAL SOLUTIONS GROUP PLC
      • 6     ALLERGAN PLC
      • 7     ALLIQUA BIOMEDICAL, INC
      • 8     ALLOSOURCE
      • 9     ALTIMED JSC
      • 10     ANGIOLOGICA BM SRL
      • 11     AROA BIOSURGERY LTD.
      • 12     ARTHREX INC
      • 13     ASPIDE MEDICAL S.A.S
      • 14     ATRIUM MEDICAL CORPORATION (MAQUET GETINGE GROUP)
      • 15     AXOGEN, INC
      • 16     AXOLOTL BIOLOGIX
      • 17     B.BRAUN
      • 18     BAXTER INTERNATIONAL INC. (SYNOVIS SURGICAL)
      • 19     BENTLEY HEALTHCARE PRIVATE LIMITED
      • 20     BETATECH MEDICAL
      • 21     BIOCER ENTWICKLUNGS-GMBH
      • 22     BIOCOMPOSITES LTD.
      • 23     BIOHORIZONS
      • 24     BIOMATLANTE
      • 25     BOSTON SCIENTIFIC
      • 26     BOTISS BIOMATERIALS GMBH
      • 27     BRAILE BIO MEDICA
      • 28     C.R.BARD INC.
      • 29     CALDERA MEDICAL INC.
      • 30     CHANGZHOU DAHUA CORP., LTD
      • 31     CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
      • 32     CL MEDICAL
      • 33     COLIBRI HEART VALVE LLC
      • 34     COLLAGEN MATRIX, INC.
      • 35     COLLPLANT HOLDINGS LTD
      • 36     COLOPLAST
      • 37     COLORADO THERAPEUTICS LLC
      • 38     CONMED
      • 39     COOK MEDICAL, INC.
      • 40     CORIN GROUP PLC
      • 41     COUSIN BIOTECH
      • 42     CRYOLIFE, INC
      • 43     CTI GROUP (VITREX MEDICAL A/S)
      • 44     DIETER MARQUARDT MEDIZINTECHNIK GMBH

      • 45     DIPROMED S.R.L
      • 46     DOLPHIN SUTURES (FUTURA SURGICARE PVT LTD)
      • 47     DSM BIOMEDICAL B.V.
      • 48     EDWARDS LIFESCIENCES
      • 49     ENDOLOGIX, INC.
      • 50     FINE SURGICALS
      • 51     GEISTLICH PHARMA AG
      • 52     GRENA LTD
      • 53     GRIKIN ADVANCED MATERIALS
      • 54     GROUPE LEPINE
      • 55     GUANHAO BIOTECH
      • 56     HARBOR MEDTECH
      • 57     HELIOSCOPIE
      • 58     HERNIA MESH S.R.L
      • 59     IN2BONES SAS
      • 60     INCISIVE SURGICAL, INC
      • 61     INION OY
      • 62     INSIGHTRA MEDICAL INC
      • 63     INTEGRA LIFESCIENCES
      • 64     INTERCUS GMBH
      • 65     JELLAGEN PTY LTD
      • 66     JENAVALVE TECHNOLOGY
      • 67     JOHNSON & JOHNSON
      • 68     JOTEC GMBH
      • 69     KATENA PRODUCTS, INC.
      • 70     KATOR
      • 71     KERECIS
      • 72     KLAS MEDICAL
      • 73     KOLLSUT USA, LLC
      • 74     LABCOR LABORATÓRIOS LTDA.
      • 75     LATTICE BIOLOGICS LTD.
      • 76     LE MAITRE VASCULAR, INC.
      • 77     LEPU MEDICAL
      • 78     LIFEBOND LTD.
      • 79     LIFENET HEALTHCARE INC
      • 80     LIFETECH SCIENTIFIC CORPORATION
      • 81     LIVANOVA PLC
      • 82     LOTUS SURGICAL PVT LTD
      • 83     MEDPRIN BIOTECH GMBH
      • 84     MEDSHAPE, INC.
      • 85     MEDTENTIA INTERNATIONAL LTD OY
      • 86     MEDTRONIC, INC
      • 87     MICRO INTERVENTIONAL DEVICES
      • 88     MIMEDX
      • 89     MIROMATRIX MEDICAL
      • 90     NANO ENDOLUMINAL S.A.
      • 91     NICAST, LTD
      • 92     NORAKER
      • 93     NOVUS SCIENTIFIC
      • 94     NURAMI MEDICAL
      • 95     OCCLUTECH INTERNATIONAL AB
      • 96     ORGANOGENESIS, INC.
      • 97     ORTHOCELL LTD.
      • 98     ORTHOD GROUP LTD
      • 99     ORTOSINTESE INDÚSTRIA E COMÉRCIO
      • 100     PARAMETRICS MEDICAL
      • 101     PFM MEDICAL AG
      • 102     PONTIS ORTHOPAEDICS, LLC
      • 103     PROXY BIOMEDICAL LTD.
      • 104     PURPLE SURGICAL
      • 105     RTI SURGICAL, INC.
      • 106     S & G BIOTECH, INC.
      • 107     SKYE ORTHOBIOLOGICS, LLC
      • 108     SMITH & NEPHEW PLC
      • 109     SOFREGEN MEDICAL INC.
      • 110     STRAIT ACCESS TECHNOLOGIES PTY LTD
      • 111     STRYKER CORPORATION
      • 112     SYNTHASOME
      • 113     TEKNIMED S.A.S.
      • 114     TELA BIO, INC.
      • 115     THT BIOSCIENCE GROUP (SWING TECHNOLOGIES)
      • 116     TISSUE REGENIX GROUP
      • 117     TISSUEGRAFT SRL
      • 118     TRANSEASY MEDICAL TECH.CO.LTD
      • 119     UNISUR LIFE CARE PVT LTD
      • 120     VALCARE MEDICAL LTD.
      • 121     VITATHREADS, LLC
      • 122     VITREX MEDICAL A/S
      • 123     W. L. GORE & ASSOCIATES, INC
      • 124     WRIGHT MEDICAL GROUP N.V
      • 125     ZIMMER BIOMET INC.